Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 […]
Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) and Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Insider and Institutional Ownership 82.0% of Centessa […]